This study aimed to establish a technical process for detecting nicotinic acetylcholine receptor (nAChR) antibodies using the transfected cell method and evaluate its application in the serological diagnosis of myasthenia gravis (MG), thereby enhancing diagnostic efficiency. This evidence concerns the gene CHRNA4 and myasthenia gravis.